Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment.

Brensilver M, Heinzerling KG, Swanson AN, Telesca D, Furst BA, Shoptaw SJ.

Drug Alcohol Rev. 2013 Jan;32(1):96-9. doi: 10.1111/j.1465-3362.2012.00423.x. Epub 2012 Mar 4.

2.

Smoking cessation interventions for smokers with current or past depression.

van der Meer RM, Willemsen MC, Smit F, Cuijpers P.

Cochrane Database Syst Rev. 2013 Aug 21;(8):CD006102. doi: 10.1002/14651858.CD006102.pub2. Review.

PMID:
23963776
3.

Pharmacological interventions for promoting smoking cessation during pregnancy.

Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J.

Cochrane Database Syst Rev. 2015 Dec 22;(12):CD010078. doi: 10.1002/14651858.CD010078.pub2. Review.

PMID:
26690977
4.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2014 Jan 8;(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Review.

PMID:
24402784
5.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
6.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
7.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007253. doi: 10.1002/14651858.CD007253.pub3. Review.

PMID:
23450574
8.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
9.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
10.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
11.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006103. doi: 10.1002/14651858.CD006103.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD006103.

PMID:
18646137
12.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
13.

An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Dean AC, Groman SM, Morales AM, London ED.

Neuropsychopharmacology. 2013 Jan;38(2):259-74. doi: 10.1038/npp.2012.179. Epub 2012 Sep 5. Review.

14.

Pharmacotherapy of amphetamine-type stimulant dependence: an update.

Brensilver M, Heinzerling KG, Shoptaw S.

Drug Alcohol Rev. 2013 Sep;32(5):449-60. doi: 10.1111/dar.12048. Epub 2013 Apr 25. Review.

15.

Pharmacological approaches to methamphetamine dependence: a focused review.

Karila L, Weinstein A, Aubin HJ, Benyamina A, Reynaud M, Batki SL.

Br J Clin Pharmacol. 2010 Jun;69(6):578-92. doi: 10.1111/j.1365-2125.2010.03639.x. Review.

Supplemental Content

Support Center